BML Investment Partners, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share (ANTX)

Filing Manager
BML Investment Partners, L.P.
Reporting Manager
BML Investment Partners, L.P.
Security
AN2 Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol
ANTX
Shares outstanding
29,944,958 shares
Disclosed Ownership
5,749,432 shares
Ownership
19.2%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 16:28:34 UTC
Date of event
31 Dec 2024
Next filing
07 May 2025
SEC
View on sec.gov

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BML Investment Partners, L.P. 19.2% 5,749,432 0 5,749,432 Braden M Leonard BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member